Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics-Reference-Cited by-同舟云学术

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics

Published:2016-01 Issue:1 Volume:2 Page:86-94
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Teunissen Charlotte E.¹,Elias Naura¹,Koel‐Simmelink Marleen J.A.¹,Durieux‐Lu Sisi¹,Malekzadeh Arjan¹,Pham Thang V.²,Piersma Sander R.²,Beccari Tommaso³,Meeter Lieke H.H.⁴,Dopper Elise G.P.⁴⁵,Swieten John C.⁴⁵,Jimenez Connie R.²,Pijnenburg Yolande A.L.⁵

Affiliation:

1. Neurochemistry Laboratory and BiobankDepartment of Clinical Chemistry, Neuroscience Campus AmsterdamVU University Medical CenterAmsterdamThe Netherlands

2. OncoProteomics LaboratoryDepartment of Medical OncologyVU University Medical CenterAmsterdamThe Netherlands

3. Department of Pharmaceutical SciencesUniversity of PerugiaPerugiaItaly

4. Department of NeurologyErasmus Medical CenterRotterdamThe Netherlands

5. Alzheimer Center & Department of Neurology, Neuroscience Campus AmsterdamVU University Medical CenterAmsterdamThe Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2015.12.004

Reference51 articles.

1. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease